Who is sponsoring NCT06058221?

NCT06058221 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT06058221?

Interventions in NCT06058221: simultaneous videolaryngoscopy, supraglottic airway.

What condition does NCT06058221 study?

NCT06058221 studies Failed or Difficult Intubation.

Is NCT06058221 still recruiting?

NCT06058221 is currently status unknown. Last updated 16 October 2023.

Last reviewed 2023-10-16 · How we verify

NCT06058221

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hybrid Intubation Technique for Difficult Airway Children

Status unknown NA Last updated 16 October 2023

What this trial tests

NA trial testing simultaneous videolaryngoscopy in Failed or Difficult Intubation in 116 participants. Status unknown.

Timeline

6 October 2023

Primary endpoint
31 July 2025

31 July 2025

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	116
Start date	6 October 2023
Primary completion	31 July 2025
Estimated completion	31 July 2025
Sites	1 location across South Korea

Drugs / interventions tested

simultaneous videolaryngoscopy
supraglottic airway

Conditions studied

Failed or Difficult Intubation — all drugs for Failed or Difficult Intubation →

Sponsor

Seoul National University Hospital

Who can join

Adults 1 Month to 12, any sex, with Failed or Difficult Intubation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare two hybrid techniques, flexible bronchoscopy-guided intubation with a video laryngoscope and flexible bronchoscopy-guided intubation with a laryngeal mask, that have recently shown promise as a way to increase first-attempt success rates and reduce complications in children with anticipated difficult intubation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06058221 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 16 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06058221.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing